These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10331759)

  • 21. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging.
    Senéterre E; Weissleder R; Jaramillo D; Reimer P; Lee AS; Brady TJ; Wittenberg J
    Radiology; 1991 May; 179(2):529-33. PubMed ID: 2014305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents.
    Mergo PJ; Engelken JD; Helmberger T; Ros PR
    J Magn Reson Imaging; 1998; 8(5):1073-8. PubMed ID: 9786144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
    Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
    J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging.
    Nakayama M; Yamashita Y; Mitsuzaki K; Yi T; Arakawa A; Katahira K; Nakayama Y; Takahashi M
    J Magn Reson Imaging; 2000 Jun; 11(6):647-54. PubMed ID: 10862064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental study of fast and ultrafast T2-weighted imaging sequences using AMI-25 superparamagnetic iron oxide (SPIO).
    Kurokawa H; Togami I; Tsunoda M; Hiraki Y
    Acta Med Okayama; 2001 Feb; 55(1):41-50. PubMed ID: 11246976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model.
    Rendon DA; Kotedia K; Afshar SF; Punia JN; Sabek OM; Shirkey BA; Zawaski JA; Gaber MW
    J Nucl Med; 2016 Feb; 57(2):266-71. PubMed ID: 26315835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients.
    Nighoghossian N; Wiart M; Cakmak S; Berthezène Y; Derex L; Cho TH; Nemoz C; Chapuis F; Tisserand GL; Pialat JB; Trouillas P; Froment JC; Hermier M
    Stroke; 2007 Feb; 38(2):303-7. PubMed ID: 17170357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls.
    Schmitz SA; Taupitz M; Wagner S; Coupland SE; Gust R; Nikolova A; Wolf KJ
    Invest Radiol; 2002 Jul; 37(7):405-11. PubMed ID: 12068163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms.
    Laghi A; Paolantonio P; Panebianco V; Miglio C; Iafrate F; Di Tondo U; Passariello R
    Invest Radiol; 2004 Nov; 39(11):666-70. PubMed ID: 15486527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice.
    Desestret V; Brisset JC; Moucharrafie S; Devillard E; Nataf S; Honnorat J; Nighoghossian N; Berthezène Y; Wiart M
    Stroke; 2009 May; 40(5):1834-41. PubMed ID: 19286601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of iron-oxide-enhanced magnetic resonance imaging of the liver: Vessel isointensity is a potential characteristic of liver hemangiomas on late T1-weighted images.
    Schmitz SA; Nikolova A; O'Regan D; Albrecht T; Hohmann J; Wolf KJ
    Acta Radiol; 2006 Sep; 47(7):634-42. PubMed ID: 16950695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol.
    Simon GH; von Vopelius-Feldt J; Fu Y; Schlegel J; Pinotek G; Wendland MF; Chen MH; Daldrup-Link HE
    Invest Radiol; 2006 Jan; 41(1):45-51. PubMed ID: 16355039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
    Schwartz LH; Seltzer SE; Tempany CM; Silverman SG; Piwnica-Worms DR; Adams DF; Herman L; Herman LA; Hooshmand R
    J Magn Reson Imaging; 1995; 5(5):566-70. PubMed ID: 8574043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
    Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
    AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
    Vellinga MM; Oude Engberink RD; Seewann A; Pouwels PJ; Wattjes MP; van der Pol SM; Pering C; Polman CH; de Vries HE; Geurts JJ; Barkhof F
    Brain; 2008 Mar; 131(Pt 3):800-7. PubMed ID: 18245785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of intrarenal distribution of ultrasmall superparamagnetic iron oxide particles by magnetic resonance imaging and modification by furosemide and water restriction.
    Trillaud H; Degrèze P; Combe C; Palussière J; Chambon C; Grenier N
    Invest Radiol; 1994 May; 29(5):540-6. PubMed ID: 8077093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.